Insider · CIK 0001194712

DUNBAR GEORGE W JR

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001194712

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2025-12-19	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$1.39	+$4,170	14,306
2025-12-19	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2025-03-03	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+750 sh	$1.39	+$1,042.5	11,306
2025-03-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,940
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,600 sh	—	—	3,600
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,750 sh	—	—	5,750
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+29.3K sh	—	—	29,250
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,920 sh	—	—	8,920
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,280
2023-02-14	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,401 sh	$1.39	+$1,947.39	10,556
2023-02-14	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,401 sh	—	—	0
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+37.8K sh	—	—	37,770
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,310 sh	—	—	8,310
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2022-03-29	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	$1.39	+$21.5K	15,455
2022-03-29	CAPRCAPRICOR THERAPEUTICS, INC.F Tax Payment	Director	FTax Payment	−6,300 sh	$3.41	−$21.5K	9,155
2022-03-29	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.5K sh	—	—	0
2022-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+63.1K sh	—	—	63,060
2021-01-04	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+71.4K sh	—	—	71,388
2020-06-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+83K sh	—	—	83,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,250 sh	—	—	5,250
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,800 sh	—	—	2,800
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,606 sh	—	—	2,606
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+750 sh	—	—	750
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,401 sh	—	—	1,401
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,455
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,250 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,800 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,606 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−750 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,401 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2019-08-08	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,250 sh	—	—	5,250
2018-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2017-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+26.1K sh	—	—	26,060
2016-06-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-03-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2010-03-11	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2010-03-10	VCELVericel CorpP Purchase	Director	PPurchase	+9,000 sh	$1.56	+$14K	12,750
2009-12-14	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+55K sh	$0.30	+$16.5K	55,000
2009-12-14	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+228K sh	$0.30	+$68.4K	228,000
2007-11-30	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+77.6K sh	$0.92	+$71.4K	77,600
2006-01-04	CALMARE THERAPEUTICS IncA Award	Director	AAward	+2,500 sh	—	—	16,109
2006-01-03	CALMARE THERAPEUTICS IncOption - Right to BuyA Award	Director	AAward	+10K sh	—	—	10,000
2005-10-04	CALMARE THERAPEUTICS IncP Purchase	Director	PPurchase	+2,200 sh	$5.83	+$12.8K	13,609
2005-05-23	ACHVACHIEVE LIFE SCIENCES, INC. · Non-qualified stock option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jan 74
DUNBAR GEORGE W JR0001194712-26-000002
SEC(opens sec.gov)
Dec 234
DUNBAR GEORGE W JR0001194712-25-000004
SEC(opens sec.gov)
Mar 44
DUNBAR GEORGE W JR0001415889-25-006735
SEC(opens sec.gov)
Jan 64
DUNBAR GEORGE W JR0001415889-25-000869
SEC(opens sec.gov)
Jan 44
DUNBAR GEORGE W JR0001415889-24-000653
SEC(opens sec.gov)
Feb 154
DUNBAR GEORGE W JR0001415889-23-002650
SEC(opens sec.gov)
Jan 54
DUNBAR GEORGE W JR0001415889-23-000594
SEC(opens sec.gov)
Mar 314
DUNBAR GEORGE W JR0001415889-22-003514
SEC(opens sec.gov)
Jan 44
DUNBAR GEORGE W JR0001415889-22-000277
SEC(opens sec.gov)

Companies

Address

C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150

SAN DIEGO, CA, 92121